Keywords
Candida
fungal
diagnostic test
Abstract
Currently, there are numerous methods available for diagnosing fungal infections that have been developed and implemented in hospitals. However, each method has its own advantages and disadvantages regarding sensitivity, accuracy, time, and so on. To improve the accuracy and speed of diagnosing fungal infections, several new methods are being tested by researchers on clinical samples. Most of these improved methods operate independently of pathogen isolation, meaning that diagnosis transitions from being considered definitive to being probabilistic. Although there is the advantage of not relying on culture, most methods lack standardization. This review aims to examine the methods for diagnosing systemic fungal infections, from diagnostic classification through methods regarded as "gold standards" to molecular techniques currently in use, and finally discuss some more future-oriented approaches.
References
[1]
M. Nucci and K. A. Marr, "Emerging fungal diseases," Clinical Infectious Diseases, vol. 41, no. 4, pp. 521-526, 2005.
Google Scholar
[2]
F. Bongomin, S. Gago, R. O. Oladele, and D. W. Denning, "Global and multi-national prevalence of fungal diseases—estimate precision," Journal of fungi, vol. 3, no. 4, p. 57, 2017.
Google Scholar
[3]
G. Janbon, J. Quintin, F. Lanternier, and C. d’Enfert, "Studying fungal pathogens of humans and fungal infections: Fungal diversity and diversity of approaches," Microbes and Infection, vol. 21, no. 5-6, pp. 237-245, 2019.
Google Scholar
[4]
A. H. Damasceno-Escoura et al., "Histoplasmosis in HIV-infected patients: epidemiological, clinical and necropsy data from a Brazilian teaching hospital," Mycopathologia, vol. 185, pp. 339-346, 2020.
Google Scholar
[5]
S. Sharma, M. Grover, S. Bhargava, S. Samdani, and T. Kataria, "Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum," The Journal of Laryngology & Otology, vol. 135, no. 5, pp. 442-447, 2021.
Google Scholar
[6]
S. Gokulshankar and B. K. Mohanty, "COVID-19 and black fungus," Asian J Med Health Sci, vol. 4, no. 1, p. 138, 2021.
Google Scholar
[7]
A. Hagen, "COVID-19-associated mucormycosis: triple threat of the pandemic," 2022.
Google Scholar
[8]
A. Mendonca, H. Santos, R. Franco-Duarte, and P. Sampaio, "Fungal infections diagnosis–past, present and future," Research in Microbiology, vol. 173, no. 3, p. 103915, 2022.
Google Scholar
[9]
A. S. Chouhan, B. Parihar, and B. Rathod, "Overuse of Steroid Drugs Methylprednisolone and Dexamethasone (Oral) Causes a Diabetic Patient to Become Infected With the Black Fungus of the Corona Virus," 2021.
Google Scholar
[10]
C. Prestel, "Candida auris outbreak in a COVID-19 specialty care unit—Florida, July–August 2020," MMWR. Morbidity and mortality weekly report, vol. 70, 2021.
Google Scholar
[11]
J. V. Mulet Bayona et al., "Impact of the SARS-CoV-2 pandemic in candidaemia, invasive aspergillosis and antifungal consumption in a tertiary hospital," Journal of Fungi, vol. 7, no. 6, p. 440, 2021.
Google Scholar
[12]
R. Franco-Duarte et al., "Advances in chemical and biological methods to identify microorganisms—from past to present," Microorganisms, vol. 7, no. 5, p. 130, 2019.
Google Scholar
[13]
J. R. Bao, R. N. Master, R. S. Jones, R. B. Clark, E. C. Moore, and K. L. Shier, "Recovery and its dynamics of filamentous fungi from clinical specimen cultures: an extensive study," Microbiology Spectrum, vol. 9, no. 1, pp. 10-1128, 2021.
Google Scholar
[14]
A. M. Borman, M. Fraser, and E. M. Johnson, "CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris," Medical mycology, vol. 59, no. 3, pp. 253-258, 2021.
Google Scholar
[15]
Y.-S. Huang et al., "High rates of misidentification of uncommon Candida species causing bloodstream infections using conventional phenotypic methods," Journal of the Formosan Medical Association, vol. 120, no. 5, pp. 1179-1187, 2021.
Google Scholar
[16]
C. Lass-Flörl, E. Samardzic, and M. Knoll, "Serology anno 2021—fungal infections: from invasive to chronic," Clinical Microbiology and Infection, vol. 27, no. 9, pp. 1230-1241, 2021.
Google Scholar
[17]
B. D. Alexander et al., "Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC/MSGERC," Clinical Infectious Diseases, vol. 72, no. Supplement_2, pp. S79-S88, 2021.
Google Scholar
[18]
I. Camp, G. Manhart, C. Schabereiter-Gurtner, K. Spettel, B. Selitsch, and B. Willinger, "Clinical evaluation of an in-house panfungal real-time PCR assay for the detection of fungal pathogens," Infection, vol. 48, pp. 345-355, 2020.
Google Scholar
[19]
P. L. White et al., "Nucleic acid tools for invasive fungal disease diagnosis," Current Fungal Infection Reports, vol. 14, pp. 76-88, 2020.
Google Scholar
[20]
J. Carvalho-Pereira et al., "Multiplex PCR based strategy for detection of fungal pathogen DNA in patients with suspected invasive fungal infections," Journal of Fungi, vol. 6, no. 4, p. 308, 2020.
Google Scholar
[21]
L. M. E. Vanhee, E. D’Haese, I. Cools, H. J. Nelis, and T. Coenye, "Detection and quantification of bacteria and fungi using solid-phase cytometry," pp. 25-41: Springer.
Google Scholar
[22]
L. M. E. Vanhee, H. J. Nelis, and T. Coenye, "Rapid detection and quantification of Aspergillus fumigatus in environmental air samples using solid-phase cytometry," Environmental science & technology, vol. 43, no. 9, pp. 3233-3239, 2009.
Google Scholar
[23]
L. M. E. Vanhee, W. Meersseman, K. Lagrou, J. Maertens, H. J. Nelis, and T. Coenye, "Rapid and direct quantification of viable Candida species in whole blood by use of immunomagnetic separation and solid-phase cytometry," Journal of clinical microbiology, vol. 48, no. 4, pp. 1126-1131, 2010.
Google Scholar
[24]
L. Potocki, J. Depciuch, E. Kuna, M. Worek, A. Lewinska, and M. Wnuk, "FTIR and Raman spectroscopy-based biochemical profiling reflects genomic diversity of clinical Candida isolates that may be useful for diagnosis and targeted therapy of candidiasis," International journal of molecular sciences, vol. 20, no. 4, p. 988, 2019.
Google Scholar
[25]
V. Erukhimovitch, V. Pavlov, M. Talyshinsky, Y. Souprun, and M. Huleihel, "FTIR microscopy as a method for identification of bacterial and fungal infections," Journal of pharmaceutical and biomedical analysis, vol. 37, no. 5, pp. 1105-1108, 2005.
Google Scholar
[26]
S. Hu et al., "Rapid detection method for pathogenic Candida captured by magnetic nanoparticles and identified using SERS via AgNPs+," International Journal of Nanomedicine, pp. 941-950, 2021.
Google Scholar
[27]
T. Sojinrin et al., "Plasmonic gold nanoparticles for detection of fungi and human cutaneous fungal infections," Analytical and bioanalytical chemistry, vol. 409, pp. 4647-4658, 2017.
Google Scholar
[28]
N. Peker, N. Couto, B. Sinha, and J. W. Rossen, "Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches," Clinical Microbiology and Infection, vol. 24, no. 9, pp. 944-955, 2018.
Google Scholar
[29]
E. Mylonakis et al., "T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial," Clinical Infectious Diseases, vol. 60, no. 6, pp. 892-899, 2015.
Google Scholar
[30]
L. Pla et al., "Oligonucleotide-capped nanoporous anodic alumina biosensor as diagnostic tool for rapid and accurate detection of Candida auris in clinical samples," Emerging microbes & infections, vol. 10, no. 1, pp. 407-415, 2021.
Google Scholar
[31]
M. G. Gerritsen et al., "Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography–mass spectrometry," Medical mycology, vol. 56, no. 2, pp. 253-256, 2018.
Google Scholar